Use of inactivated Escherichia coli enterotoxins to enhance respiratory mucosal adjuvanticity during vaccination in swine

Clin Vaccine Immunol. 2011 Nov;18(11):1996-8. doi: 10.1128/CVI.05273-11. Epub 2011 Sep 14.

Abstract

In order to augment responses to respiratory vaccines in swine, various adjuvants were intranasally coadministered with a foot-and-mouth disease virus (FMDV) antigen to pigs. Detoxified Escherichia coli enterotoxins LTK63 and LTR72 enhanced antigen-specific mucosal and systemic immunity, demonstrating their efficacy as adjuvants for nonreplicating antigens upon intranasal immunization in swine.

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Adjuvants, Immunologic / administration & dosage*
  • Administration, Intranasal
  • Animals
  • Antibodies, Neutralizing / blood
  • Antibodies, Viral / blood
  • Bacterial Toxins / administration & dosage*
  • Bacterial Toxins / genetics
  • Blood / immunology
  • Enterotoxins / administration & dosage*
  • Enterotoxins / genetics
  • Escherichia coli Proteins / administration & dosage*
  • Escherichia coli Proteins / genetics
  • Foot-and-Mouth Disease / immunology
  • Foot-and-Mouth Disease / prevention & control*
  • Foot-and-Mouth Disease Virus / immunology*
  • Immunity, Mucosal
  • Immunoglobulin A / analysis
  • Immunoglobulin G / blood
  • Swine
  • Toxoids / administration & dosage*
  • Toxoids / genetics
  • Vaccination / methods*
  • Viral Vaccines / administration & dosage
  • Viral Vaccines / immunology*

Substances

  • Adjuvants, Immunologic
  • Antibodies, Neutralizing
  • Antibodies, Viral
  • Bacterial Toxins
  • Enterotoxins
  • Escherichia coli Proteins
  • Immunoglobulin A
  • Immunoglobulin G
  • Toxoids
  • Viral Vaccines
  • heat-labile enterotoxin, E coli